Skip to content

Clinical trials

Phase 3 Bronchiolitis Obliterans Syndrome trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Phase: Phase 3 Country / region: Italy Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20071
20112
20121
20131
20142
20172
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting3
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation3
Novartis Pharmaceuticals2
Pharmacyclics LLC.2
AstraZeneca1
Dompé Farmaceutici S.p.A1
GlaxoSmithKline1
Hoffmann-La Roche1
Janssen Research & Development, LLC1
Pfizer1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome15
Leukemia3
Leukemia, Lymphocytic, Chronic, B-Cell3
Graft vs Host Disease2
Pulmonary Disease, Chronic Obstructive2
Anemia1
Arthralgia1
Arthritis, Juvenile1
Bone Marrow Diseases1
Bronchitis1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.